Our findings revealed that VPA treatment enhanced G6PD activity, leading to an increase in NADPH levels and a decrease in the NADP+/NADPH ratio in wild type cells, a response that was not observed in G6PD knockdown HCC cells (Figure 8F-G). The gene discussed is G6PD; the disease is hepatocellular carcinoma.